Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non–small cell lung cancer previously treated with crizotinib: Results from ASCEND-6
Titel:
Phase 1/2 study of ceritinib in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non–small cell lung cancer previously treated with crizotinib: Results from ASCEND-6
Auteur:
Wu, Yi-Long Shi, Yuankai Tan, Daniel Shao Weng Xiaoqing, Liu Cheng, Ying Zhou, Jianying An, Tong Tong Lu, You Zhu, Bo Bai, Chunxue Passos, Vanessa Q. Lau, Yvonne Y. Xun, Liao Zhang, Li